Change of Nominated Advisor
In brief · summary, not quotable
No summary for this filing – the full text is below.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your SCLP notes
Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer, is pleased to announce that Panmure Gordon (UK) Limited has been appointed as the Company's Nominated Advisor with immediate effect and will continue as Joint Broker.
This announcement contains insider information for the purposes of Article 7 of Regulation (EU) 596/2014 (MAR)
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.